Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
FIVE PRIME THERAPEUTICS, INC. (FPRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2022 SC 13G/A Rock Springs Capital Management LP reports a 0% stake in Five Prime Therapeutics, Inc.
05/17/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
03/08/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2020 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/05/2020 SC 13G/A BlackRock Inc. reports a 7% stake in FIVE PRIME THERAPEUTICS INC
12/09/2019 SC 13G/A WELLINGTON MANAGEMENT GROUP LLP reports a 3.5% stake in Five Prime Therapeutics, Inc.
11/12/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/08/2019 SC 13G/A BIOTECHNOLOGY VALUE FUND L P reports a 16.4% stake in Five Prime Therapeutics, Inc.
10/02/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/10/2019 SC 13G/A FMR LLC reports a 5% stake in FIVE PRIME THERAPEUTICS INC
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2019 SC 13G/A FMR LLC reports a 10.5% stake in FIVE PRIME THERAPEUTICS INC
02/13/2019 SC 13G/A STATE STREET CORP reports a 3.6% stake in EXIT FILING Five Prime Therapeutics, Inc.
02/12/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/11/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/04/2019 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
10/04/2018 SC 13G/A BIOTECHNOLOGY VALUE FUND L P reports a 10.1% stake in Five Prime Therapeutics, Inc.
02/13/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/25/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/10/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/09/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/09/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
01/23/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/16/2016 SC 13G/A Point72 Asset Management, L.P. reports a
02/16/2016 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/11/2016 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy